BlackRock Institutional Trust’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$372K Hold
213,649
﹤0.01% 3503
2016
Q3
$709K Sell
213,649
-3
-0% -$11 ﹤0.01% 3400
2016
Q2
$919K Sell
213,652
-99,293
-32% -$449K ﹤0.01% 3335
2016
Q1
$1.76M Sell
312,945
-6,183
-2% -$80.3K ﹤0.01% 3091
2015
Q4
$5.49M Buy
319,128
+38,098
+14% +$908K ﹤0.01% 2673
2015
Q3
$5.93M Sell
281,030
-9,318
-3% -$319K ﹤0.01% 2622
2015
Q2
$14.4M Sell
290,348
-29,662
-9% -$1.77M ﹤0.01% 2151
2015
Q1
$25.1M Buy
320,010
+2,138
+0.7% +$133K ﹤0.01% 1798
2014
Q4
$19.3M Sell
317,872
-25,157
-7% -$1.26M ﹤0.01% 1937
2014
Q3
$14.6M Buy
343,029
+27,749
+9% +$1.49M ﹤0.01% 2083
2014
Q2
$19.5M Buy
315,280
+17,477
+6% +$1.02M ﹤0.01% 1978
2014
Q1
$19.4M Buy
297,803
+14,590
+5% +$987K ﹤0.01% 1984
2013
Q4
$15.9M Buy
283,213
+7,224
+3% +$406K ﹤0.01% 2108
2013
Q3
$16.9M Buy
275,989
+10,081
+4% +$683K ﹤0.01% 1988
2013
Q2
$15.5M Buy
+265,908
New +$16.4M ﹤0.01% 2007

Other funds holding OREX